Placebo-controlled crossover comparison of spirapril at 3, 6, 12 and 24 mg once daily in mild to severe essential hypertension. [electronic resource]
Producer: 19940922Description: 61-8 p. digitalISSN:- 0803-8023
- Adolescent
- Adult
- Aged
- Analysis of Variance
- Angiotensin-Converting Enzyme Inhibitors -- administration & dosage
- Blood Pressure -- drug effects
- Blood Pressure Determination
- Drug Administration Schedule
- Enalapril -- administration & dosage
- Female
- Humans
- Hypertension -- blood
- Male
- Middle Aged
- Renin-Angiotensin System -- drug effects
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.